Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Oncoimmunology|March 3, 2020
Tumor-targeting oncolytic virus elicits potent immunotherapeutic vaccine responses to tumor antigensYong Luo, Chaolong Lin, Yidi Zou, et al.
Cancer Research|March 24, 2025
SLC3A2-Mediated Lysine Uptake by Cancer Cells Restricts T cell Activity in Hepatocellular CarcinomaYating Chang, Naizhen Wang, Shaopeng Li, et al.
Frontiers in Bioengineering and Biotechnology|January 22, 2025
Biomimetic bioreactor for potentiated uricase replacement therapy in hyperuricemia and goutBin Yang, Guihu Luo, Tailei Nie, et al.
Plos One|March 4, 2014
IL-17A signaling in colonic epithelial cells inhibits pro-inflammatory cytokine production by enhancing the activity of ERK and PI3KXiaoqin Guo, Xingwei Jiang, Yan Xiao, et al.
Nature Communications|January 3, 2024
Pharmaceutical targeting of OTUB2 sensitizes tumors to cytotoxic T cells via degradation of PD-L1Wenfeng Ren, Zilong Xu, Yating Chang, et al.
Molecular Vision|February 12, 2011
Exploring the retinal connectomeJames R Anderson, Bryan W Jones, Carl B Watt, et al.
Cancer Immunology Research|April 17, 2024
Orchestrated Codelivery of Peptide Antigen and Adjuvant to Antigen-Presenting Cells by Using an Engineered Chimeric Peptide Enhances Antitumor T-Cell ImmunityHaifeng Pan, Siyuan Yu, Haoyun Zhuang, et al.
Nature Communications|March 1, 2026
Targeting leucine-rich repeat kinase 2 overcomes resistance to oncolytic herpes simplex virus-based therapies in glioblastomaYaning Qin, Zhiqi Liang, Mengqin Yu, et al.
Journal for Immunotherapy of Cancer|June 10, 2022
Oncolytic virus expressing PD-1 inhibitors activates a collaborative intratumoral immune response to control tumor and synergizes with CTLA-4 or TIM-3 blockadeFei Ju, Yong Luo, Chaolong Lin, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 27, 2023
The potential of swine pseudorabies virus attenuated vaccine for oncolytic therapy against malignant tumorsGuosong Wang, Jiali Cao, Mengxuan Gui, et al.
Pageof 4